Beken Bio
Beken Bio is a biotechnology company focused on revolutionizing early cancer detection through minimally invasive liquid biopsies. Their proprietary 3D REVEAL™ engine uses a unique 3D cell growth platform and AI technology to identify novel cancer biomarkers in blood before symptoms appear, enabling early diagnosis and effective treatment. The company aims to reduce cancer-related deaths by providing clinically qualified diagnostic tests that detect cancer at its earliest stage, leveraging extracellular vesicles and enriched antigens to unlock molecular signatures specific to cancer types. Beken Bio operates in the cancer diagnostics market with a mission to shift cancer detection to earlier stages using advanced nanobiology and machine learning AI, positioning itself as a pioneer in early cancer screening technology.
Beken Bio
Beken Bio is a biotechnology company focused on revolutionizing early cancer detection through minimally invasive liquid biopsies. Their proprietary 3D REVEAL™ engine uses a unique 3D cell growth platform and AI technology to identify novel cancer biomarkers in blood before symptoms appear, enabling early diagnosis and effective treatment. The company aims to reduce cancer-related deaths by providing clinically qualified diagnostic tests that detect cancer at its earliest stage, leveraging extracellular vesicles and enriched antigens to unlock molecular signatures specific to cancer types. Beken Bio operates in the cancer diagnostics market with a mission to shift cancer detection to earlier stages using advanced nanobiology and machine learning AI, positioning itself as a pioneer in early cancer screening technology.